Sernova Corp. Price Target Cut to C$2.50/Share From C$3.00 by Ventum Financial

Dow JonesSep 13 23:49 · Ratings

Sernova Corp. Is Maintained at Buy by Ventum Financial

Dow JonesSep 13 23:49 · Ratings

Sernova Corp Unveils Advancements at Investor Conference

TipRanksSep 5 20:18

Sernova Corp Launches $4 Million Private Placement

TipRanksAug 20 20:18

Sernova Corp. Announces Appointment of New Chief Executive Officer

GlobeNewswireAug 12 19:45

Sernova Announces Additional Patient Insulin Independent and Cohort 2 Enrollment Complete in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes

Stockhouse Jun 25 19:00